Jazz Pharmaceuticals EVP Samantha Pearce's Stock Transaction

Samantha Pearce, EVP and Chief Commercial Officer of Jazz Pharmaceuticals plc, reported a transaction involving the disposal of 577 ordinary shares on August 5, 2025. The shares were sold at a price of $116.10 per share, resulting in a total transaction value of approximately $66,989.70. Following this transaction, Pearce owns 40,815 ordinary shares. The shares disposed of were withheld to satisfy tax obligations arising from the vesting of previously granted restricted stock units. Additionally, Pearce acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025. This filing provides transparency into the stock transactions of a key executive at Jazz Pharmaceuticals.